{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:12:59Z","timestamp":1792059179914,"version":"4.4.0"},"reference-count":34,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the safety and efficacy of intradetrusor onabotulinum toxin A injections for the treatment of overactive bladder (OAB) in patients with Parkinson's disease (PD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All PD patients who underwent intradetrusor injections of onabotulinum toxin A (BoNT\u2010A) for storage symptoms between 2010 and 2017 were included in a retrospective study. A 100\u2009U dose of BoNT\u2010A (Botox\u00ae, Allergan Irvine, CA) was used for the first injection in all patients. The primary endpoint was clinical success defined as any subjective improvement in OAB symptoms self\u2010assessed by the patients 4 weeks after the injections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 24 patients analyzed, 19 reported improvement of their OAB symptoms 4 weeks after the first injection (79.2%) with complete resolution of urgency urinary incontinence in seven patients (29.1%; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The average post\u2010void residual (PVR) increased significantly after the first injection from 17.6 to 125.3\u2009mL (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Three of the patients had to start clean intermittent catheterization (CIC) after the first injection (12.5%). Out of 49 injections in total, only five caused incomplete bladder emptying requiring the use of CIC (10.2%). Higher pre\u2010injection PVR was significantly associated with both a lower chance of symptomatic improvement (<jats:italic>P<\/jats:italic>\u2009=\u20090.04) and a higher risk of incomplete bladder emptying with institution of CIC (<jats:italic>P<\/jats:italic>\u2009=\u20090.047).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Intradetrusor injections of BoNT\u2010A 100\u2009U appeared as a safe and effective option in PD patients with OAB symptoms and a low PVR before the injection. Higher preoperative PVR was the strongest predictor of both treatment failure and postoperative urinary retention requiring CIC.<\/jats:p><\/jats:sec>","DOI":"10.1002\/nau.23717","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T10:20:18Z","timestamp":1526466018000},"page":"2669-2677","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's disease"],"prefix":"10.1002","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3971-7554","authenticated-orcid":false,"given":"Gregory","family":"Vurture","sequence":"first","affiliation":[{"name":"Department of Urology New York University School of Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Peyronnet","sequence":"additional","affiliation":[{"name":"Department of Urology New York University School of Medicine New York New York"},{"name":"Department of Urology University of Rennes Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Feigin","sequence":"additional","affiliation":[{"name":"The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders New York University School of Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton C.","family":"Biagioni","sequence":"additional","affiliation":[{"name":"The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders New York University School of Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gilbert","sequence":"additional","affiliation":[{"name":"The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders New York University School of Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirit","family":"Rosenblum","sequence":"additional","affiliation":[{"name":"The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders New York University School of Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Frucht","sequence":"additional","affiliation":[{"name":"The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders New York University School of Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Di Rocco","sequence":"additional","affiliation":[{"name":"The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders New York University School of Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor W.","family":"Nitti","sequence":"additional","affiliation":[{"name":"Department of Urology New York University School of Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Brucker","sequence":"additional","affiliation":[{"name":"Department of Urology New York University School of Medicine New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"121","volume-title":"Parkinson's Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care","year":"2006"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63247-0.00019-5"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2016.254"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2017.04.008"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13187"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-013-2250-4"},{"key":"e_1_2_6_8_1","unstructured":"Food and Drug Administration Center for devices and radiological health. Available at:http:\/\/www.fda.gov\/cdrh\/safety\/neurostim.html"},{"key":"e_1_2_6_9_1","unstructured":"Medtronic Inc Urology. Available at:http:\/\/www.medtronic.com\/physician\/interstim\/disclosure.html"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67283-7"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22631"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.purol.2013.09.020"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.02.004"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.07.002"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.01.125"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2010.06.006"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.04.071"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-016-0174-2"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2013.09.017"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.06.023"},{"key":"e_1_2_6_21_1","first-page":"S14","article-title":"Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction","volume":"7","author":"Nitti VW","year":"2005","journal-title":"Rev Urol"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1999.00121.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10473"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23429"},{"key":"e_1_2_6_25_1","first-page":"518","article-title":"Proposed classification of complication of surgery with examples of utility in cholecystectomy","volume":"111","author":"Clavien P","year":"1992","journal-title":"Surgery"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.5213\/inj.2015.19.3.185"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.03.045"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.12.022"},{"key":"e_1_2_6_29_1","first-page":"193","article-title":"Sacral neuromodulation in overactive bladder: a review and current perspectives","volume":"8","author":"Sukhu T","year":"2016","journal-title":"Res Rep Urol"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2016.07.495"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-016-3225-z"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22764"},{"key":"e_1_2_6_33_1","first-page":"351","article-title":"Effects of sacral neuromodulation on urinary and fecal incontinence","volume":"17","author":"Rosen A","year":"2015","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.07.001"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.05.033"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.23717","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.23717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T08:54:59Z","timestamp":1694681699000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.23717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1002\/nau.23717"],"URL":"https:\/\/doi.org\/10.1002\/nau.23717","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"value":"0733-2467","type":"print"},{"value":"1520-6777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"2018-02-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}